Masimo Change in Accounts Payable 2010-2025 | MASI

Masimo change in accounts payable for the twelve months ending June 30, 2025 was $0.041B, a 200.99% decline year-over-year.

  • Masimo annual change in accounts payable for 2024 was $0.015B, a 175.51% decline from 2023.
  • Masimo annual change in accounts payable for 2023 was $-0.02B, a 132.4% decline from 2022.
  • Masimo annual change in accounts payable for 2022 was $0.061B, a 450% increase from 2021.

Masimo Change in Accounts Payable 2010-2025 | MASI

  • Masimo annual change in accounts payable for 2024 was $0.015B, a 175.51% decline from 2023.
  • Masimo annual change in accounts payable for 2023 was $-0.02B, a 132.4% decline from 2022.
  • Masimo annual change in accounts payable for 2022 was $0.061B, a 450% increase from 2021.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$185.3B
Intuitive Surgical (ISRG)$167.9B
IDEXX Laboratories (IDXX)$51.3B
Edwards Lifesciences (EW)$47.5B
Alcon (ALC)$39.8B
IQVIA Holdings (IQV)$32B
DexCom (DXCM)$29.8B
Mettler-Toledo (MTD)$26.6B
STERIS (STE)$24.5B
Waters (WAT)$17.8B
SONOVA HOLDING (SONVY)$17B
Hologic (HOLX)$14.9B
Penumbra (PEN)$10.3B
Globus Medical (GMED)$8.3B
Sysmex ADR (SSMXY)$8.1B
Teleflex (TFX)$5.6B
Glaukos (GKOS)$5.3B
TransMedics (TMDX)$3.9B
Integer Holdings (ITGR)$3.8B
LivaNova (LIVN)$3.1B
Alphatec Holdings (ATEC)$2.3B
Veracyte (VCYT)$2.3B
PROCEPT BioRobotics (PRCT)$2.2B
Artivion (AORT)$2.1B
Nihon Kohden (NHNKY)$1.9B
Elekta AB (EKTAY)$1.9B
Integra LifeSciences Holdings (IART)$1.1B
Pulse Biosciences (PLSE)$1.1B
OPKO Health (OPK)$1.1B
Paragon 28 (FNA)$1.1B